High-Precision radiation blitz targets scattered cancer spots in major trial
NCT ID NCT03721341
Summary
This study is testing whether using very precise, high-dose radiation to destroy all visible spots of cancer that have spread (4-10 spots) helps people live longer and better than standard care alone. It is for adults whose original tumor is under control and who have a limited number of small, treatable metastases. The goal is to see if aggressively treating these spots can control the cancer's spread for a longer time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Health
Melbourne, Victoria, 3181, Australia
-
BC Cancer Agency, Vancouver Island Centre
Victoria, British Columbia, V8R 4X1, Canada
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Centre hospitalier de l'Université de Montréal-CHUM
Montreal, Quebec, H2X 0C1, Canada
-
Grand River Hospital
Kitchener, Ontario, N2G 1G3, Canada
-
Health Sciences North
Greater Sudbury, Ontario, P3E 5J1, Canada
-
London Regional Cancer Program of the Lawson Health Research Institute
London, Ontario, N6A 5W9, Canada
-
Niagra Health System
St. Catharines, Ontario, L2S 0A9, Canada
-
Nova Scotia Health Authortiy
Halifax, Nova Scotia, B3S 0H6, Canada
-
Trillium Health Partners-Credit Valley Hospital
Mississauga, Ontario, L5M 2N1, Canada
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada
-
University Hospital of Zürich
Zurich, 8091, Switzerland
-
VU University Medical Centre
Amsterdam, Netherlands
-
Western General Hospital
Edinburgh, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.